Literature DB >> 21786721

Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa?

Joseph N Jarvis1, Thomas S Harrison, Nelesh Govender, Stephen D Lawn, Nicky Longley, Tihana Bicanic, Gary Maartens, Francois Venter, Linda-Gail Bekker, Robin Wood, Graeme Meintjes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21786721     DOI： 10.7196/samj.4752

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  10 in total

Review 1.  Treatment principles for Candida and Cryptococcus.

Authors:  Laura C Whitney; Tihana Bicanic
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

2.  Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa.

Authors:  Snigdha Vallabhaneni; Nicky Longley; Mariette Smith; Rachel Smith; Meg Osler; Nicola Kelly; Anna Cross; Andrew Boulle; Graeme Meintjes; Nelesh P Govender
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

3.  Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Ann Percival; Sean Bauman; Joy Pelfrey; Graeme Meintjes; G Ntombomzi Williams; Nicky Longley; Thomas S Harrison; Thomas R Kozel
Journal:  Clin Infect Dis       Date:  2011-09-21       Impact factor: 9.079

Review 4.  Host immunity to Cryptococcus neoformans.

Authors:  Soma Rohatgi; Liise-Anne Pirofski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

5.  Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.

Authors:  Tafese Beyene; Yimtubezinash Woldeamanuel; Daniel Asrat; Gonfa Ayana; David R Boulware
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

Review 6.  Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?

Authors:  Juergen Prattes; Sven Heldt; Susanne Eigl; Martin Hoenigl
Journal:  Curr Fungal Infect Rep       Date:  2016-04-07

7.  Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals.

Authors:  Naseem Cassim; Lindi Marie Coetzee; Kathryn Schnippel; Deborah Kim Glencross
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

8.  Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.

Authors:  Naseem Cassim; Kathryn Schnippel; Lindi Marie Coetzee; Deborah Kim Glencross
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

9.  An audit of the screen-and-treat intervention to reduce cryptococcal meningitis in HIV-positive patients with low CD4 count.

Authors:  Egide Ndayishimiye; Andrew J Ross
Journal:  Afr J Prim Health Care Fam Med       Date:  2018-08-08

10.  Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.

Authors:  Lindi-Marie Coetzee; Naseem Cassim; Charlotte Sriruttan; Mabatho Mhlanga; Nelesh P Govender; Deborah Kim Glencross
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.